NEWS

IN THE NEWS

Home > News
Results per page:
Former Chief of Medical Oncology at Memorial Sloan Kettering Cancer Center-Commack, Long Island Joins eviti's Hematology-Oncology Medical Office Philadelphia, PA [July 15, 2013] - eviti, Inc. has appointed Dr. Philip Schulman to the position of Medical Director, Hematology-Oncology. As part of the eviti Medical Office team, Dr. Schulman's responsibilities include reviewing ...
06/04/2013 news-releases Billions of Dollars in Potential Savings
Philadelphia, PA [June 3, 2013] - eviti, Inc., an independent health information technology and oncology decision-support company, released results of a multi-year study performed in association with professionals from Abramson Cancer Center of the University of Pennsylvania and Johns Hopkins Carey Business School. The study showed that 28.7% of cancer ...
Philadelphia, PA [May 30, 2013] - eviti, Inc., an independent health information technology and oncology decision-support company, to demonstrate new, more powerful version of its market leading decision-support platform in booth 4044 at the 2013 ASCO Annual Meeting, with general availability during July 2013. The latest version known as eviti ...
03/07/2013 news-releases AIM Specialty Health Partners with eviti
AIM Specialty Health, a national leader in specialty benefits management, has announced a strategic collaboration with eviti, Inc. to create an enhanced oncology management solution that helps ensure appropriate, safe and affordable cancer care. eviti is the leader in oncology clinical decision-support focused on improving the quality and reducing ...
Philadelphia, PA - eviti, Inc. announces that Heather Curry, M.D. has joined eviti as Medical Director, Radiation Oncology. Dr. Curry will oversee radiation oncology treatment plan review for adherence to national standards and interface with treating physicians and payers. As part of the eviti Medical Office team, her role ...
eviti Medical Advisory Board Welcomes New Member Reshma Jagsi, M.D., Ph.D. Radiation Oncology Researcher Philadelphia, PA - eviti, Inc., an independent health information technology and oncology decision-support company, recently announced that Dr. Reshma Jagsi, Associate Professor of Radiation Oncology at the University of Michigan has joined 14 other expert oncology ...
CureMD's Oncology EHR - First to Include Real-Time Oncology Clinical Decision Support New York, NY - CureMD's Oncology EHR, a specialty product of CureMD's Smart Cloud EHR solutions, now includes real-time oncology clinical decision support through eviti, Inc., a national leader in oncology clinical information. Physicians using CureMD's Oncology EHR will now ...
eviti, Inc. and Aetna (NYSE: ?ET) announced a joint program today that will help speed the identification and use of the best clinical practices in cancer care. Beginning later this year, participating Aetna oncologists in New York and New Jersey will have access to eviti's evidence-based, decision support tool. The ...
eviti, Inc., an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care, announced today that Dr. Deborah K. Armstrong joins 13 other expert oncology specialists who advise eviti's professional staff on new cancer treatments and evolving standards of care within their specialties. Dr. Armstrong ...
eviti, Inc., an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care, announces the appointment of Elizabeth Tapen, M.D. to the position of Director, Radiation Oncology. Board certified in Radiation Oncology, Dr. Tapen was Medical Director of the Ulster Radiation Oncology Center ...
Eduardo Beruff Will Speak on Panel at World Congress Leadership Summit Eduardo Beruff, CEO and President of eviti, Inc. and entrepreneur in health care coordination technology, has accepted an invitation to take part in a panel on coordinated care at the World Congress Leadership Summit on Clinical Integration and Care Coordination. ...
TripleTree Announces the 2012 iAwards Finalists Twelve companies are recognized for their innovative wireless health solutions. Minneapolis, MN - Today, TripleTree announced the 2012 TripleTree iAwards for Wireless Health finalists. Twelve finalists, four in three different categories, were selected from a field of more than 160 nominated companies. "The number of quality nominations ...
Philadelphia, PA, February 29, 2012 - eviti, Inc. (formerly known as ITA Partners), an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care, announces that Stephen Grund, M.D., Ph.D. has joined the company as Medical Director, Oncology. Dr. Grund has broad experience in both ...
ST. PAUL, MN - February 23, 2012 - Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM), has announced its new oncology management program designed to improve the quality and value of cancer care for patients. Prime plans to partner with two oncology management companies in bringing this new capability ...
eviti, Inc. (formerly known as ITA Partners) will showcase its innovative business model, facilitating and aligning high-quality cancer care delivery with appropriate payment, at the first Care Innovations Summit in Washington, DC on January 26th, 2012. The event, hosted by the Center for Medicare & Medicaid Innovation, Office of the ...
Philadelphia, PA (January 18, 2012) - eviti, Inc. (formerly known as ITA Partners, Inc.) announced today that it has deployed eviti® | Clinical Trials as an enhancement to its oncology decision-support platform. Physicians using the eviti solution now have access to information on thousands of federally registered cancer clinical trials ...
01/17/2012 news-releases ITA Partners Becomes eviti, Inc.
ITA Partners, Inc. announced that it has officially changed its company name to eviti, Inc. The new name reflects the company's transformation to a health information technology business delivering web-based decision-support services to improve the quality of cancer care and reduce cost - beyond oncology pathways. eviti is the culmination ...
eviti, Inc. (formerly ITA Partners) announced today that Maryland Physicians Care (MPC) will use its proprietary oncology decision-support platform to improve oncology care and manage costs for its patients. MPC physicians will use the web-based platform to improve adherence to evidence-based care for cancer patients and to obtain preauthorization for treatment ...
07/06/2011 testimonials Medical Director, Georgia-based HMO
"Oncology risk management requires attention to detail, great sensitivity when talking to patients, respect from their doctors, tremendous oncology expertise, and access to leading experts. Further, it demands an advanced, yet easy-to-use infrastructure to support and facilitate all of those functions. eviti excels in all of these areas. It has ...
"When eviti gets involved, it's like a new family comes into your life. No matter why I called, our eviti nurse always helped. She got information for us ... She made sure I understood everything, and if I didn't understand, she'd review it with me and help me figure out ...
04/14/2011 news-releases DAKOTACARE Turns to eviti
Philadelphia, PA - April 14, 2011 - DAKOTACARE, a South Dakota managed care organization, owned by the South Dakota State Medical Association and focused on keeping patient care decisions in the hands of physicians, has contracted to implement eviti, Inc.'s proprietary web-based oncology decision-support platform across its comprehensive local network ...
04/13/2011 news-releases FCCN Network Physicians Adopt eviti
Philadelphia, PA - April 13, 2011 - The Florida Comprehensive Care Network (FCCN) and eviti, Inc., have signed a long term strategic agreement under which FCCN will use eviti's oncology decision-support platform, across its network of oncologists. eviti, Inc. is an independent, third-party expert with nearly a decade of experience ...
04/04/2011 articles Archive
Americans treated, over-treated until death The Associated Press offers a look at how American medicine includes ongoing treatment - without real discussions of options - even as patients face imminent death.  Rosaria Vandenberg went home to share a final, touching moment with her 2-year-old daughter one day before dying of an ...
04/01/2011 testimonials RB, Breast Cancer Patient in Tennessee
"I was skeptical. A company that would support me, helping me attain best-possible care, yet linked to me through my insurer? Well, I can tell you - it IS true. eviti gets treatments approved quickly. They run interference. When I need medication, they work to secure it at a good ...
"eviti provides meaningful continuity of care. Even in the best treatment situations, care can be fragmented across hospitals, doctors' offices and patients' homes. eviti bridges the gaps, collaboratively and professionally. When patients and families are distressed, eviti spends time with them. eviti helps them understand diagnoses and treatment, while focusing ...
03/09/2011 news-releases ADVANTAGE Health Solutions, Inc.
Philadelphia, PA - March 9, 2011 - To improve outcomes and manage costs for members with cancer, ADVANTAGE Health Solutions, Inc. (ADVANTAGE) has contracted with eviti, Inc. to implement their proprietary oncology decision-support platform across their provider network. eviti is an independent, third-party expert with nearly a decade of experience ...
01/12/2011 news-releases Texas Municipal League (TML)
Philadelphia, PA - January 12, 2011 - eviti, Inc., an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care, today announced that it has signed an agreement with TML Intergovernmental Employee Benefit Pool (TML) to implement its proprietary eviti system to ensure that ...
12/15/2010 news-releases Health Plan Select Chooses eviti
Philadelphia, PA, December 15, 2010 - eviti, Inc., an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care, today announced that it has signed an agreement with Health Plan Select to implement its proprietary eviti solution to streamline system-wide processes for the delivery ...
12/09/2010 news-releases GEHA Selects eviti
Philadelphia, PA, December 9, 2010 - eviti, Inc., an independent, third-party expert with nearly a decade of experience in transforming the quality of oncology care, today announced that Government Employees Health Association (GEHA) has chosen eviti's proprietary oncology decision-support platform - to ensure prompt authorization of care and improve clinical ...
ONCOLOGY & BIOTECH NEWS - November 2010 Issue   OP-ED By Eduardo Beruff  Nowhere today is there a greater need for a unified solution to improve access to care, patient outcomes, and cost-efficiency than in cancer care. Comprising hundreds of different diseases with thousands of therapeutic choices, cancer seems to defy a simple ...
DOTMED - November 2010 Issue   by Olga Deshchenko, DOTmed News Reporter This report originally appeared in the November 2010 issue of DOTmed Business News  As one of the world's deadliest killers, cancer remains the medical community's arch enemy. While new guidelines and research continues to help doctors battle the disease, these tools also ...
09/28/2010 news-releases URAC Awards eviti with Accreditation
eviti, Inc. receives URAC Health Utilitation Management Accreditation Philadelphia, PA, September 28, 2010 - eviti, Inc. announced today that it has been awarded Health Utilization Management Accreditation from URAC, a Washington DC-based health care accrediting organization that establishes quality standards for the health care industry. URAC's Health Utilization Management Accreditation standards ...
Philadelphia, PA, April 26, 2010 - Arlene Forastiere, MD, SVP of Medical Affairs at eviti, Inc., and an internationally recognized expert in the treatment of cancers of the head, neck, larynx and esophagus, and professor at Johns Hopkins University School of Medicine, has accepted an invitation to participate on the ...
01/22/2010 articles Oncology Buy-and-Bill Evolving
DRUG TOPICS - January 2011 Issue   Oncology treatment and benefits are changing. Buy-and-bill, the traditional methodology that had physicians buying chemotherapeutic products, treating in the office, and billing the payer, is going the way of surgery by barbers. But no one is quite sure what will replace the one-time standard of ...